Search results
Results from the WOW.Com Content Network
Paromomycin is an inexpensive (US$10) and effective treatment for leishmaniasis. The treatment is determined by where the disease is acquired, the species of Leishmania, and the type of infection. [2] For visceral leishmaniasis in India, South America, and the Mediterranean, liposomal amphotericin B is the recommended treatment and is often ...
Visceral leishmaniasis (VL), also known as kala-azar (Hindi: kālā āzār, "black sickness") [2] or "black fever", is the most severe form of leishmaniasis and, without proper diagnosis and treatment, is associated with high fatality. [3] Leishmaniasis is a disease caused by protozoan parasites of the genus Leishmania.
Cutaneous leishmaniasis is the most common form of leishmaniasis affecting humans. [4] It is a skin infection caused by a single-celled parasite that is transmitted by the bite of a phlebotomine sand fly. There are about thirty species of Leishmania that may cause cutaneous leishmaniasis.
Leishmania / l iː ʃ ˈ m eɪ n i ə,-ˈ m æ n-/ [1] is a parasitic protozoan, a single-celled organism of the genus Leishmania that is responsible for the disease leishmaniasis. [2] [3] [4] They are spread by sandflies of the genus Phlebotomus in the Old World, and of the genus Lutzomyia in the New World.
Leishmania donovani is a species of intracellular parasites belonging to the genus Leishmania, a group of haemoflagellate kinetoplastids that cause the disease leishmaniasis. It is a human blood parasite responsible for visceral leishmaniasis or kala-azar, the most severe form of leishmaniasis.
Leishmania mexicana can induce the cutaneous and diffuse cutaneous clinical manifestations in humans and certain other mammalian hosts. The cutaneous type develops an ulcer at the bite site, here the amastigotes do not spread and the ulcers become visible either a few days or several months after the initial bite.
L. tropica causes a broad spectrum of leishmaniasis forms in humans. Most common is a variant called dry-type cutaneous leishmaniasis. After an incubation period lasting more than 2 months, a small brownish nodular lesion will appear with a slowly extending plaque reaching a size of 1–2 centimetres (0.39–0.79 in) after 6 months.
In Brazil, currently, the most common treatment for humans to cure leishmaniasis is the drug meglumine antimoniate. [3] About 80 percent of patients with cutaneous leishmaniasis respond successfully to the drug, but for disseminated leishmaniasis only 40 percent are successfully cured of the disease after one treatment, so in these cases the ...